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Abstract
Background: Circadian organisation of behavioural and physiological rhythms in mammals is
largely driven by the clock in the suprachiasmatic nuclei (SCN) of the hypothalamus. In this clock,
a molecular transcriptional repression and activation mechanism generates near 24 hour rhythms.
One of the outputs of the molecular clock in specific SCN neurons is arginine-vasopressin (AVP),
which is responsive to transcriptional activation by clock gene products. As negative regulators, the
protein products of the period genes are thought to repress transcriptional activity of the positive
limb after heterodimerisation with CRYPTOCHROME. When both the Per1 and Per2 genes are
dysfunctional by targeted deletion of the PAS heterodimer binding domain, mice lose circadian
organization of behaviour upon release into constant environmental conditions. To which degree
the period genes are involved in the control of AVP output is unknown.
Methods: Using an in vitro slice culture setup, SCN-AVP release of cultures made of 10 wildtype
and 9 Per1/2 double-mutant mice was assayed. Mice were sacrificed in either the early light phase
of the light-dark cycle, or in the early subjective day on the first day of constant dark.
Results: Here we report that in arrhythmic homozygous Per1/2 double-mutant mice there is still
a diurnal peak in in vitro AVP release from the SCN similar to that of wildtypes but distinctively
different from the release pattern from the paraventricular nucleus. Such a modulation of AVP
release is unexpected in mice where the circadian clockwork is thought to be disrupted.
Conclusion: Our results suggest that the circadian clock in these animals, although deficient in
(most) behavioural and molecular rhythms, may still be (partially) functional, possibly as an
hourglass mechanism. The level of perturbation of the clock in Per1/2  double mutants may
therefore be less than was originally thought.
Background
Many behavioural and physiological processes in mam-
mals show circadian (circa 24-hour) rhythms that are
entrained to the daily light-dark cycle. These rhythms are
governed by internal circadian clocks. The main, light
entrainable oscillator is housed in the suprachiasmatic
nuclei of the hypothalamus (SCN, [1,2]). As an output of
the SCN, Arg8-vasopressin (AVP) is expressed predomi-
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nantly in the dorsomedial subregion of the SCN, also
called the shell [3,4], and circadian rhythms in SCN-AVP
transcription, peptide content and release have been
reported [5-10].
Functionally, SCN-AVP content and release have been cor-
related with variation in behavioural rhythmicity in voles
[8,11,12] but cannot be held exclusively responsible for
the control of rhythmic organization of behaviour. Brat-
tleboro rats, not expressing functional AVP, still show cir-
cadian rhythms in activity – albeit with a decreased
amplitude – and entrain to a light dark schedule [13,14].
Species-specific correlation between strength of circadian
organization of behaviour and SCN-AVP content
[11,15,16] or SCN-AVP release [12] suggest a role for
SCN-AVP in the output of the SCN in these species. This
correlation between SCN-AVP content/release and behav-
iour is not necessarily controlled by transcriptional con-
trol of the clock [5,17], but can also be a result of
posttranscriptional regulation [18]. Whether, and to
which degree, components of the circadian clock in the
SCN are involved in the transcriptional control of SCN-
AVP is the central question of this study. We focus on
SCN-AVP release in mice with deletions rendering the
Period1 and Period2 genes dysfunctional, genes that are
supposed to be essential parts of the molecular circadian
clock in the SCN [19-21].
The presumed pacemaker mechanism in the SCN consists
of two interlocking feedback loops of clock gene transcrip-
tion and translation. In mammals, one loop consists of
two transcription factors, Clock, being constitutively
expressed [22,23] and Bmal1  (Mop3, Arntl), showing
cyclic expression with peak activity in the mid-dark period
[24-26]. The protein products CLOCK and BMAL1 form
heterodimers which in the nucleus act as e-box binding
transcriptional activators [27,28]. In the other loop of the
molecular clockwork, the cryptochrome proteins (CRY1
and CRY2) [29,30] strongly inhibit CLOCK:BMAL1 acti-
vated transcription [31,32]. The role of the period genes
(Per1, Per2, and Per3 [33-36]) is more diverse, but each of
the mPer genes can inhibit CLOCK:BMAL1 activated tran-
scription [5], possibly by heterodimerization to CRY and
subsequent translocation into the nucleus, making them
part of the negative limb of the feedback loop.
The role of each of the three known Per genes has been
studied at the behavioural and molecular level separately
in corresponding mutant mice. The circadian phenotypes
of mPer mutants differ for the three period genes. Mice
with a mutation in the mPer1 gene (either the mPer1brdm1
mutation ([19], called Per1m/m from here on) or an mPer1-
null mutant [37] show persistent circadian rhythms in
constant darkness with a variable, but shorter period than
wildtype mice. Mice carrying the mPer2brdm1  mutation
([20], called Per2m/m from here on) exhibit an impaired
circadian phenotype. They initially show a circadian
rhythm with a short period in DD, but after a few days
completely lose circadian rhythmicity in behaviour [20].
Interestingly, under constant illumination levels (LL),
both Per1m/m and Per2m/m show persistent circadian behav-
ioural rhythms, where with increasing light intensity
Per1m/m mice show increased lengthening of the free-run-
ning period length tau and Per2m/m mice show shortening
of tau [38,39]. Mice with a targeted disruption of the
mPer3  gene express largely normal circadian rhythms
under entrained and free-run conditions, with shorter
periods than wildtype animals in DD [40].
Different effects of Per mutations are also found at the
molecular level. While mPer1ldc mutant animals show no
difference from wildtype controls in the expression of
mPer2, mCry1 and Bmal1 in the SCN, the amplitude in cir-
cadian variation in SCN mPER2 and mCRY1 proteins is
markedly reduced [41]. Also in the Per1m/m and the Per1
null mutant mice no difference in core clock gene expres-
sion is seen in the SCN [37,19]. In the periphery, the Per1
null mutant (but not the Per1m/m) shows prolonged mPer1
and mPer2 gene expression [37,19]. The impaired behav-
ioural circadian phenotype of the mPer2ldc mutant mice
coincides with decreased amplitudes of mPer1 and mCry1
gene expression in the SCN, whereas mPer2 and Bmal1
expression are no longer rhythmic. Levels of SCN mPER1
and CRY1 protein are expressed in a circadian rhythm,
albeit with a decreased amplitude [41]. Also in the
mPer2m/m, the amplitude mPer1 and mPer2 expression is
low and the circadian oscillation is lost, and Bmal1 levels
are truncated and phase advanced, suggesting an addi-
tional role for mPer2  as a positive regulator of Bmal1
[19,42].
Per1/2 double-mutant mice lose rhythmicity immediately
after release into constant dark [19] as do mPer1ldcmPer2ldc
[41] indicating a complete disruption of the clock.
Mutants carrying an mPer3  mutation and either the
mPer1ldc or mPer2ldc mutation do not show circadian phe-
notypes that are more severe than the single mPer1ldc or
mPer2ldc mutation [41]. The behavioural phenotype of the
homozygous  Per1m/mPer2m/m  double-mutant mice sug-
gests that both genes are essential for the generation of cir-
cadian rhythms and cannot be substituted by Per3 while a
certain degree of redundancy between both Per1 and Per2
is apparent [19].
When the double mutation in Per1 and Per2 is combined
with a mutation in one of the binding partners Cry1 or
Cry2 to form triple knock out animals, again an arrhyth-
mic behavioural phenotype is seen [43]. In these animals,
all rhythms in SCN-AVP are lost. To address the question
whether post transcriptional regulation of SCN-AVPJournal of Circadian Rhythms 2008, 6:5 http://www.jcircadianrhythms.com/content/6/1/5
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depends on the presence of the Per1 and Per2 genes we
used a fully automated acute slice culture system to meas-
ure SCN and paraventricular AVP release in brain slices
from homozygous Per1m/mPer2m/m mutants.
Materials and Methods
Animals
Mice homozygous for both the mPer1m/m and mPer2m/m
mutation ([19-21], from here onwards denoted as Per1m/
mPer2m/m) (N = 10) and congenic wildtype mice (N = 9),
derived from a C57Bl/6 × 129/sv mixed background stock
originally received from U. Albrecht, were bred in our
mouse facility in Haren, The Netherlands. Adult male
Per1m/mPer2m/m  homozygote double-mutant mice and
wildtype mice originating from Per1m/+ × Per1m/+ and a
Per2m/+ × Per2m/+ breeding lines were housed individually
in translucent cages (Macrolon type 1 long) equipped
with a running wheel (∅14 cm) and passive infrared
detection (PIR) on the cage lids. Prior to entrainment to a
LD schedule, Per1m/mPer2m/m mutant mice were kept in
constant darkness for two weeks. Activity measurements,
binned in two minute intervals, were recorded on our
Event Recording System (ERS) and stored for behavioural
analysis. Food and tap water were available ad libitum and
cages were placed in a sound attenuated, temperature con-
trolled room (22 ± 0.5°C; 60% humidity; light intensity
250–350 lux, depending on cage placement).
Mice were entrained to a 14 hrs light: 10 hrs dark cycle
(LD 14:10) for at least 2 weeks before being sacrificed for
culturing. Before the onset of the experiment, mice either
remained under LD 14:10 or lights were not turned on at
the last morning. For culturing of SCN tissue, mice were
sacrificed in the first half of the light period (External
Time 9.9 ± 0.7 (SEM), ExT; [44], N = 13) or in the first day
of dark in the first half of the subjective day (Internal Time
8.3 ± 0.2 (SEM), InT, N = 7). All experiments were
approved by the Animal Experimentation Committee of
the University of Groningen (DEC No. 2595).
Culturing
Animals were deeply anesthetized by inhalation of isoflu-
rane (Forene, Abbott laboratories) and transferred to a
'clean room', with a slight overpressure and HEPA filtered
air flow. Animals were then briefly dipped in 70% ethanol
and immediately decapitated. The whole brain was dis-
sected out and rinsed in ice-cooled, sterile and oxygenated
Gey's balanced salt solution for two minutes. Brains were
trimmed down to a block containing the hypothalamus
using a handheld scalpel. After trimming a hand operated
tissue chopper (tissue slicer 51425, Stoelting, Illinois,
USA) was used to cut coronal sections of 300 µm, contain-
ing the SCN. Under a dissection microscope a section con-
taining the mid-part of the SCN was selected and was
trimmed to the height and width of the two SCN nuclei,
leaving a bilateral SCN slice explant including the optic
chiasm of approximately 1 by 1 mm and a thickness of
300 µm. For two Per1m/mPer2m/m mutant mice (one sacri-
ficed in LD and one sacrificed in DD) similar sized sec-
tions of the paraventricular nucleus of the hypothalamus
(PVN) were made. All sections were stored in oxygenized
Gey's balanced salt solution for 2 to 3 hours, at 4°C.
Acute slice cultures were prepared in a small culture well
in our custom built automated culture system with a con-
tinuous medium flow kept in a laminar flow cabinet. In
brief, cultures were placed in a small culturing well milled
out of anodized aluminium which was continuously kept
at a temperature of 37 ± 0.26°C and was filled with carbo-
genated Earle's balanced salt solution with NaHCO3
(Sigma-Aldrich; with added antifungal antibiotic Ampho-
tericin B (2 mg/l)). When all cultures were placed, the lid
was mounted, closing off all the individual chambers
from each other and the outside environment, except for
a decompression tube leading into a small flow of carbo-
gen, making sure that the system was not pressurized.
Upon closing, the medium was flushed through the wells
at a speed of 325 µl/hour per well. Well volume was 160
µl, thus at these perfusion rates the exchange rate was ~2×
per hour. Cultures remained stationary in the well and
were submersed in the medium. The medium outflow
containing the release products of the culture of the indi-
vidual wells was collected immediately at -40°C, starting
a new collection every 2 hours. Samples were kept at -
40°C until further analysis.
Radio Immuno Assay
For the Radio Immuno Assay a standard kit by Euro-Diag-
nostica (Mediphos) was used. In short, all samples were
analyzed in duplicate and a standard dilution curves rang-
ing from 0.47 to 60 pmol/liter (corresponding to an in
vitro SCN-AVP release of 0.329 – 42 fmol/2 hours), a low
and a high control were included in every assay. The assay
applies an 125I-labelled AVP tracer (1700 – 2100 µCi/
nmol) as readout, with primary antibody rabbit anti-AVP
which is precipitated by a solid phase secondary antibody
(goat anti-rabbit IgG) bound to cellulose. Individual val-
ues of AVP release were expressed as fmol/2 hours.
Using circular statistics, individual release profiles were
checked for rhythmicity using a harmonic regression anal-
ysis (2 harmonics, CircWave [45]). Grouped release data
was represented as percentage of average. Peaks in AVP
release were identified using t-tests for each time point (a
modified 'least significant difference' (LSD) method),
comparing average values for each time point to the aver-
age level of the group throughout the time series using a
significance level of 0.05. As a control, data points were
randomly selected from the dataset and analysed similarly
as the release data.Journal of Circadian Rhythms 2008, 6:5 http://www.jcircadianrhythms.com/content/6/1/5
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Results
In our hands Per1m/mPer2m/m  double-mutant mice are
arrhythmic whereas wildtype mice show robust free-run-
ning circadian rhythms in DD with a period of 23.72 hrs
(SEM = 0.06 hrs, N = 12, [46]). For the Per1m/mPer2m/m
double-mutant mice, behavioural arrhythmicity in DD is
confirmed by the rhythmicity index (maximal ∆qP ± SEM
within 20–28 hrs, [46]) which was negative (-180.25 ±
18.12, N = 12), while the robust behavioural rhythms of
wildtype mice have maximal values of 2507.35 ± 193.10
at their respective periods of free-running rhythms in
DD(N = 12) (see Fig. 1).
Average SCN-AVP release during the first 24 hours (± SD,
maximum release) was assayed at 2.61 (± 1.63, max =
13.04) fmol/2 hours for wildtype and 1.87 (± .06, max =
Activity patterns and genotypes Figure 1
Activity patterns and genotypes. A) Double plotted actogram of a wildtype mouse (left panel) and a Per1m/mPer2m/m dou-
ble-mutant mouse (right panel) during a period of light-dark 12:12 followed by a free running rhythms in continuous dim red 
light. B) Genotyping example of four animals used in this study. Using the same primer sets, lane 1 and 3 show the lighter PCR 
products for the Per1 and the Per2 fragments indicating the Per1m/mPer2m/m double-mutant genotype in both mice, lane 2 and 4 
show the heavier PCR products for both genes indicating the Per1+/+Per2+/+ genotype in both mice. Molecular weight scales are 
in kiloDalton.Journal of Circadian Rhythms 2008, 6:5 http://www.jcircadianrhythms.com/content/6/1/5
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6.86) fmol/2 hours for Per1m/mPer2m/m mutant mice. Lev-
els of release did not differ between wildtypes and Per1m/
mPer2m/m mutant mice, between mice sacrificed in LD or
DD nor was there an interaction effect of genotype and
time of sacrifice on overall levels of release (two-way
ANOVA; P's > 0.05). Individual SCN-AVP release profiles
are shown in Figure 2. For both the wildtype and Per1m/
mPer2m/m mutant mice the individual curves in LD show
strong variation over time with similar peak levels. All
individual SCN cultures showed significant circadian
rhythmicity in the release pattern between ExT 10–44 h
(except one culture from WT mice under LD, which suf-
fered from missing data). The detected rhythmicity in the
circadian domain with periods between 18–32 h (p <
0.015 corrected for multiple period testing (CircWave
[45], Harmonic regression with two harmonics).
For mice sacrificed in DD peak SCN-AVP release levels
within individual Per1m/mPer2m/m mice seem to vary more
in phase and amplitude than wildtype mice. The slope of
linear decline during the session was on average -0.046 ±
0.027 for wildtypes and -0.027 ± 0.019 for Per1m/mPer2m/
m mutant mice, indicating that the variability of both cul-
tures was similar (t-test, P > 0.05).
Individual release patterns of AVP from in vitro SCN slice cultures Figure 2
Individual release patterns of AVP from in vitro SCN slice cultures. Slice cultures were made from wildtype (upper 
panels) and Per1m/mPer2m/m double-mutant mice (lower panels). Release pattern is shown as a function of external time, extrap-
olated from time of sacrifice. Right panels show release patterns of mice sacrificed during LD, and left panels show release pat-
terns of mice sacrificed during the first day of DD. All cultures showed significant circadian rhythmicity in AVP release pattern 
with periods between 18–32 h, between ExT 10–44 h (except one culture from WT mice under LD). Different line types indi-
cate SCN-AVP release of an individual culture. Black/grey bars indicate projected night and day, respectively.Journal of Circadian Rhythms 2008, 6:5 http://www.jcircadianrhythms.com/content/6/1/5
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As a control, paraventricular AVP release of Per1m/mPer2m/
m mutant mice was measured, shown in Figure 3. Release
was constantly high at the beginning of the culturing with
no detectable circadian fluctuation, but decreased after
time (slopes are -1.2 and -0.8 for PVN cultures taken from
DD and LD respectively). Average paraventricular AVP
release of the first 24 hours was 35.56 (± 13.31) fmol/2
hours, with a maximal value of 58.03 fmol/2 hours. SCN-
AVP release was significantly lower than paraventricular
AVP release (Mann-Whitney Rank Sum Test, P < 0.001).
The two left panels in Figure 4 show average SCN-AVP
release profiles of cultures made from wildtype and Per1m/
mPer2m/m mutant mice sacrificed in the first half of the
light period. After a decline in SCN-AVP release in the first
hours of culturing, levels increased to peak levels in the
beginning of the extrapolated day and subsequently
decreased again. Comparing the release levels of individ-
ual time points to culturing average indicate significantly
elevated diurnal levels of SCN-AVP release in the extrapo-
lated external (ExT) 6–12 for wildtypes and ExT 6 for
Per1m/mPer2m/m (Least square difference (LSD) test); P's <
0.01). Although the diurnal peak in SCN-AVP release in
cultures made of Per1m/mPer2m/m mice was less distinct, the
timing was similar to that of the wildtype controls.
In Figure 4, the right panels show average release profiles
of SCN-AVP of cultures made of wildtype and Per1m/
mPer2m/m mutant animals sacrificed on the first day of DD.
SCN-AVP release profiles did not show a marked initial
high level of SCN-AVP release as did those of animals sac-
rificed in LD. Both cultures made of wildtype and Per1m/
mPer2m/m  mutant animals showed increasing levels of
SCN-AVP release peaking in the extrapolated day. The
LSD test against the average level of each group indicates
significant increased levels at ExT 8 and 10 for wildtypes
and ExT 10, 14 and 16 for Per1m/mPer2m/m mutants, which
is later than for the animals sacrificed in LD.
The diurnal peak in SCN-AVP expression in cultures made
from wildtype mice shows similar peak phasing in ani-
mals sacrificed in LD (ExT 6–12) and animals sacrificed in
DD (ExT 8–10). SCN-AVP release in cultures made from
Per1m/mPer2m/m shows a peak release with a similar phase
compared to wildtype when sacrificed in LD (ExT 6), but
is delayed when animals are sacrificed in DD (ExT 10, 14–
16), indicative for a longer inter-peak interval or period.
SCN-AVP release values were randomly selected out of all
release data and averaged in 2-h bins (Fig. 4, "shuffled").
The pattern through these points is different from that of
the release profiles and essentially flat. Using the same sta-
tistical method that was used to identify significantly ele-
vated levels of SCN-AVP release in the cultures does not
identify any significant changes in AVP levels for any data
point.
Discussion
In our in vitro culture system both cultures made of
wildtype and Per1m/mPer2m/m double-mutant mice show
rhythmic AVP release patterns with peak secretion of AVP
well after onset of culturing. Although our data do not
conclusively indicate rhythmicity in the in vitro release of
SCN-AVP in wildtype and Per1m/mPer2m/m double-mutant
mice – because of the lack of multiple cycles – the patterns
of SCN-AVP release do fluctuate over time as would be
predicted from SCN-AVP release in vitro [9,10]. Moreover,
the data indicate that this fluctuation does not differ
between wildtype and Per1m/mPer2m/m  double-mutant
mice. The attenuation of PVN-AVP release over time indi-
cates that in our culturing method, no evidence of multi-
ple circadian cycles in AVP release can be seen, we can
therefore not distinguish between a circadian and an
hourglass process. The flat and dissimilar profiles seen
when the dataset is randomly sampled and the marked
differences between SCN- and PVN-AVP release profiles in
our data do however suggest a non random SCN-AVP
release with peak release levels that are similarly timed
between wildtype and Per1m/mPer2m/m  double-mutant
mice, but are not seen in the gradually decreasing levels of
PVN-AVP release. While individual curves of Per1m/
mPer2m/m double-mutant mice sacrificed in DD do suggest
greater variation in phase and amplitude within individ-
ual, correcting for these individual amplitude differences
through expressing average profiles as percent of average
release, rather than absolute release shows clear peaked
Paraventricular AVP release Figure 3
Paraventricular AVP release. Shown is the average spon-
taneous paraventricular AVP release of 2 SCN cultures made 
from Per1m/mPer2m/m double-mutant mice (one sacrificed in 
LD and one in DD). Paraventricular release is different from 
that of the SCN in both quantity and shape.Journal of Circadian Rhythms 2008, 6:5 http://www.jcircadianrhythms.com/content/6/1/5
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release. It is not unlikely that the loss of the Per1 and Per2
gene may be involved in the greater variance of AVP
release in the SCN cultures of these individuals, but such
impairment does not lead to loss of peaks in release.
Mice carrying both the Per1m/m and the Per2m/m mutations
show an arrhythmic circadian phenotype [19]. Core clock
gene expression is severely impaired in these mice, indic-
ative of a disrupted circadian clock. A similar SCN-AVP
Average SCN-AVP release patterns for cultures made from wildtype (upper panels) and Per1m/mPer2m/m double-mutant mice  (lower panels) Figure 4
Average SCN-AVP release patterns for cultures made from wildtype (upper panels) and Per1m/mPer2m/m dou-
ble-mutant mice (lower panels). Percent of average release and SEM are plotted in external time, extrapolated from the 
time of sacrifice. Left panels show release patterns of mice sacrificed during LD, right panels show release patterns of mice sac-
rificed during the first day of DD. The very bottom right panel shows the profile of randomly selected samples. Asterisks indi-
cate samples with a release level significantly deviating from the average (modified LSD test; P < 0.05). Horizontal dashed lines 
depict the SEMs. Black/grey bars indicate projected night and day, respectively.Journal of Circadian Rhythms 2008, 6:5 http://www.jcircadianrhythms.com/content/6/1/5
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release between wildtype and Per1m/mPer2m/m  double-
mutant mice may be indicative for a partially intact clock
mechanism. Remaining functionality could possibly
include a strongly damped oscillator or an hour glass
mechanism, but our data do not prove any residual oscil-
lator function. In SCN slices of mCry1/mCry2  double-
mutant mice (also carrying a disrupted clock), a single
peak in electrical activity has been reported [47]. This peak
was only seen when the animals were sacrificed at the
beginning of the light period, but not when they were sac-
rificed at the beginning of dark. The authors hypothesized
that the absence of such a peak in electrical activity in
slices of animals sacrificed at the beginning of the dark
might result from the fact that activity is induced by the
light exposure and not by the culturing technique. In our
case, release of SCN-AVP induced directly by light is less
likely as both animals sacrificed in the light phase of the
LD cycle and animals sacrificed in the dark on the first day
in DD showed a peak in SCN-AVP release. If, in our case,
an hourglass mechanism underlies our ex vivo SCN-AVP
release, it cannot be driven by light. However, we cannot
completely exclude other unknown factors related to our
culturing technique, which might drive the observed
peaks in AVP release.
It is known that serum in the medium of tissue cultures
can affect cellular rhythmicity. In cultured fibroblasts, cir-
cadian rhythms are induced (possibly due to synchroniza-
tion of the single cells) and reset by serum shock [48].
More recently, fibroblast cultures of multiple clock gene
knock out mice including Cry1-/-Cry2-/- have been shown to
respond to a medium change by increased Per2 expression
[49]. One of the mechanisms by which this can be
achieved is through the nuclear localization of mPER pro-
teins in response to an unknown serum signal [50]. A one-
time induction of the negative limb of the clock (possibly
through residual functionality of Per1m/m  and  Per2m/m
products, or the intact Per3 gene) could result in one (par-
tial) oscillation resulting in an hour glass-like effect.
As mentioned above, light does not seem to turn on this
hour glass, but some phasing effects of light in release pat-
terns of SCN-AVP in our cultures may be present.
Although the peak of SCN-AVP release of wildtype mice is
less pronounced in DD than in LD, the timing of the peak
of AVP release of wildtype mice in LD and DD does not
suggest being very different. From our data we can how-
ever not clearly establish a phase or period in SCN-AVP
release in cultures from wildtype mice from DD. In Per1m/
mPer2m/m double-mutant mice, the timing of the peak in
SCN-AVP release in DD is markedly later than in LD.
While in vivo these animals are arrhythmic in DD and the
clock is perturbed, this delayed peak in DD in comparison
to LD could be indicative of a long intrinsic period, only
apparent under specific circumstances.
The extent to which the circadian clock is disabled by
knocking out Period genes is unclear. Xu et al. [51] reported
that when the Per2ldc mutation was crossed into a C57B/6J
background (different from the original 129/sv back-
ground in [41]), the behavioural phenotype of a short tau
and eventual circadian arrhythmicity in DD is lost and a
wildtype phenotype is rescued. The level of perturbation
of the clock by Period deletion thus seems highly depend-
ant on the genetic background. Our findings support this
view of a (partially) functional clock. While not conclu-
sive, the data presented here on timed peaks in in vitro
SCN-AVP release in Per1m/mPer2m/m double mutants raise
the possibility of partial preservation of a clock function
in these mice. They might raise questions to what extend
the clock function is disabled in Per1m/mPer2m/m double
mutants.
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